Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05643859 · ClinicalTrials.gov registry record · NA

Impact of Dietary Fiber Supplementation on Colonic Microbiome

A NA study of Benign Colorectal Neoplasm and Non-Neoplastic Anal Disorder, sponsored by OHSU Knight Cancer Institute.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05643859 is a NA study of Benign Colorectal Neoplasm and Non-Neoplastic Anal Disorder that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05643859, a NA study of Benign Colorectal Neoplasm and Non-Neoplastic Anal Disorder, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This clinical trial tests whether daily fiber supplementation will change the mucosal microbiome of the colon. The microbiome are microorganisms that live in the human gut. They serve a vital role in maintaining health. Certain microbial strains are associated with the growth of colon polyps, which eventually could go on to form colon cancer. Giving dietary fiber supplements may help prevent precancerous polyps from ever developing.

Interventions

  • PROCEDURE Colonoscopy
  • OTHER Questionnaire Administration
  • DIETARY_SUPPLEMENT Dietary Fiber
  • PROCEDURE Proctoscopy or anoscopy with Biopsy

Study Locations (1)

Oregon

  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-04-01
Est. Completion 2026-12-31
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

What the Registry Record Tells You About NCT05643859

The ClinicalTrials.gov registry entry for NCT05643859 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Benign Colorectal Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Colonoscopy is the first listed.

NCT05643859 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05643859 about?

NCT05643859 is a clinical study titled "Impact of Dietary Fiber Supplementation on Colonic Microbiome". This clinical trial tests whether daily fiber supplementation will change the mucosal microbiome of the colon. The microbiome are microorganisms that live in the human gut. They serve a vital role in maintaining health. Certain microbial strains are associated with the growth of colon polyps, which ...

What is the current status of trial NCT05643859?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-04-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05643859 study?

This clinical trial studies the following conditions: Benign Colorectal Neoplasm, Non-Neoplastic Anal Disorder.

What interventions are being tested in trial NCT05643859?

The interventions under investigation include: Colonoscopy (PROCEDURE), Questionnaire Administration (OTHER), Dietary Fiber (DIETARY_SUPPLEMENT), Proctoscopy or anoscopy with Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT05643859?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05643859 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.